869631-11-8

869631-11-8 structure
869631-11-8 structure
  • Name: O-Desethyl candesartan cilexetil
  • Chemical Name: 1-cyclohexyloxycarbonyloxyethyl 2-oxo-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1H-benzimidazole-4-carboxylate
  • CAS Number: 869631-11-8
  • Molecular Formula: C31H30N6O6
  • Molecular Weight: 582.60600
  • Create Date: 2018-06-17 12:08:52
  • Modify Date: 2024-01-11 14:46:38

Name 1-cyclohexyloxycarbonyloxyethyl 2-oxo-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1H-benzimidazole-4-carboxylate
Synonyms 2-oxocandesartan cilexetil
UNII-JC6R5VA63B
desethyl-condesartan
2,3-Dihydro-2-oxo-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester
CNS-desethyl
desethyl-CNS
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate
O-Desethyl Candesartan Cilexetil
Candesartan Cilexetil Impurity 2
Molecular Formula C31H30N6O6
Molecular Weight 582.60600
Exact Mass 582.22300
PSA 154.34000
LogP 5.62600
RIDADR NONH for all modes of transport

~%

869631-11-8 structure

869631-11-8

Literature: KRKA, D.D. NOVO MESTO Patent: WO2007/42161 A1, 2007 ; Location in patent: Page/Page column 16-17 ;

~88%

869631-11-8 structure

869631-11-8

Literature: Havllcek, Jaroslav; Mandelova, Zuzana; Weisemann, Ruediger; Strelec, Ivo; Placek, Lukas; Radl, Stanislav Collection of Czechoslovak Chemical Communications, 2009 , vol. 74, # 2 p. 347 - 362

~70%

869631-11-8 structure

869631-11-8

Literature: Havllcek, Jaroslav; Mandelova, Zuzana; Weisemann, Ruediger; Strelec, Ivo; Placek, Lukas; Radl, Stanislav Collection of Czechoslovak Chemical Communications, 2009 , vol. 74, # 2 p. 347 - 362

~%

869631-11-8 structure

869631-11-8

Literature: TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. Patent: WO2006/122254 A2, 2006 ; Location in patent: Page/Page column 12; 13 ;

~%

869631-11-8 structure

869631-11-8

Literature: TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. Patent: WO2006/122254 A2, 2006 ; Location in patent: Page/Page column 12; 13 ;
Precursor  2

DownStream  0